Xu et al. reported that low levels of hemoglobin, albumin, lymphocyte, and platelet could serve as a significant risk factor for recurrence-free survival and overall survival in patients with resected pancreatic cancer [51]. This evidence concerns the gene ALB and pancreatic neoplasm.